This year’s SCRS Site Solutions Summit was the biggest ever, and for good reason—sites are coming into their own in the clinical trial value chain. Not only are sites maturing their operations and sending more staff to events like SCRS to learn, but sponsors have also realized that connections with sites are more important [...]
While presenting at Central Monitoring Summit 2018, Elizabeth Robinson of Horizon Pharma shared a strong data point: In the coming years, Clinical Research Associates (CRAs) will experience more change to their jobs than any other research profession (2017 Applied Clinical Trials survey). This statement spurred a conversation amongst the room about what will change [...]
The rate of cancer death has been decreasing, and people are living longer with cancer than ever before. Approximately 64% of US patients diagnosed with cancer in 2005 have lived 10 years or more beyond diagnosis, up from 35% for those diagnosed in 1975. — American Society of Clinical Oncology Cancer Advances Report, 2018. [...]
As Featured in Clinical Leader, July 13 2017 Clinical research has a reputation for being notoriously slow to adopt new technologies. This should come as no surprise to those in the industry, since we operate in a highly regulated environment. We’re generally skeptical about technology for three main reasons: Potential data security and compliance [...]
Gartner’s Michael Shanler was one of the first to recognize the trend of dClinical. He noticed that a new generation of software vendors was emerging who handled project management and reporting in a new way. Florence agrees with Michael’s observation, which is why we’re building tools that align with a dClinical approach. An abbreviated [...]
Florence, the company advancing clinical research through software, will be presenting at the 2017 Montgomery Summit this week in Santa Monica California. The Montgomery Summit chose Florence to present from a field of over 4,000 applicants. Presenters represent the most impressive and innovative companies in their fields, including enterprise software, cloud infrastructure, cybersecurity, marketing [...]
What’s your eRegulatory Strategy? In the last year we’ve met with dozens of research teams to discuss this question. In the process, we've discovered that moving to an eRegulatory platform is much more than moving from paper to digital documents. Formulating a site-wide strategy for eRegulatory means considering 1) the benefits you seek, 2) [...]
Emerging technology company chosen as the most innovative in clinical research at Disruptive Innovations 2016. Atlanta, Ga- Florence Healthcare, a software platform company focused on improving clinical trial site and sponsor collaboration, won the 2016 DPharm Idol competition in Boston last week. Disruptive Innovations (DPharm) is an annual event that discusses solutions in clinical [...]
The transition to electronic clinical trial binders (eBinders or investigator site files) is underway across the clinical research industry. eBinders provide several advantages for your site. Well-understood benefits include: Improved compliance. Digital binders allow you to easily track and fix compliance issues so that your site is always audit-ready - no paper sticky notes [...]
Florence Healthcare snags cash to switch trial sites from paper to the cloud Florence Healthcare has picked up seed funding to help clinical trial sites switch from paper files to the cloud. The funding positions a team that cut its teeth at AirWatch and Microsoft ($MSFT) to build on its early successes, such as [...]
When discussing eSource there is as much detail to explore as any other segment of clinical trial operations. But from small biotechs to top 20 pharma, the starting point for discussions is more simple: how do we define eSource? After numerous deployments of eBinders and eBinders eSource, we've come to understand that eSource is three things. First, let's [...]
EDC and eTMF applications streamline data capture for sponsors, but what is the rest of the digital story for sites? How close is the industry really to linking electronic source and moving beyond three-ring regulatory binders? Hear what lies in store for sites in 2016 and how digitization can affect investigator oversight, document processes, [...]
This year we’ve met with 45 pharmaceutical, biotech, and device sponsors about both risk-based and remote-based monitoring (the combination referred to as RBM), and we’re seeing sponsors migrate to RBM in very different ways. We encountered three main RBM positions: Source: Florence HC industry interviews, 2015 Targeted. 50% have moved [...]
